A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors

Condition:   Advanced or Metastatic Solid Tumors
Interventions:   Drug: INCB001158;   Drug: Epacadostat;   Drug: Pembrolizumab
Sponsor:   Incyte Corporation
Not yet recruiting

http://ift.tt/2iM3qdj